Equivalent price position
Unlock the full competitive price benchmark
See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Linezolid
- Therapeutic area
- Anti-infectives
- Drug class
- Oxazolidinone antibacterials
- ATC
- J01
- Strength
- 600 mg/300 mL
- Dosage form
- IV infusion
- Pack
- 1’s
- Registration no.
- 077082
- Price record verified
- 2026-08-08
- Latest DRAP source check
- 2026-11-14 03:07
Manufacturer
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →What Resbact (Linezolid) is used for
Linezolid is an antibiotic from a group called oxazolidinones. It works by stopping the bacteria that cause an infection from growing. It is a prescription-only medicine that comes as tablets or a liquid to swallow, and you will usually need regular blood tests while you take it.
- Pneumonia (a serious lung infection)
- Some serious skin and soft tissue infections
- Some chest and bone infections, often allowing treatment to continue at home with tablets instead of a hospital drip
- Drug-resistant tuberculosis (TB), as one part of combination treatments recommended by WHO
Get medical help straight away if
- Get emergency help for signs of a severe allergic reaction: swelling of the face or neck, wheezing, trouble breathing or swallowing, a widespread rash or a fast heartbeat.
- Get urgent help for any change in your eyesight, such as blurred vision, changes in how you see colours, or loss of side vision.
- Get urgent help for bleeding gums, black tarry stools, or unexpected bleeding or bruising.
- Get urgent help for fits (seizures) or a severe headache.
Side effects, warnings and interactions for Linezolid
Prepared from the sources listed by the MedInfoBase team. General information, not medical advice: it gives no doses. Your doctor or pharmacist decides the medicine and dose for you.
About Resbact 600 mg/300 mL IV infusion
Resbact 600 mg/300 mL IV infusion contains Linezolid 600 mg/300 mL. It is registered with DRAP by Saffron Pharmaceuticals (registration no. 077082). Its official price is PKR 1,256.31 for a pack of 1’s. This price has applied since 29 July 2026. Resbact is also available as 100 mg/5 mL dry suspension and 200 mg/100 mL IV infusion. 21 other brands of Linezolid 600 mg/300 mL (IV infusion) are registered in Pakistan. Compare all brands and prices →
Other strengths of Resbact
All 21 other brands of Linezolid 600 mg/300 mL infusion in Pakistan
These 21 brands are alternatives (substitutes) to Resbact: each contains Linezolid 600 mg/300 mL infusion. Ask your doctor or pharmacist before you switch brands.
Sorted by price per unit, lowest first. The lowest is Linox (Nabiqasim Industries (Pvt) Ltd) at PKR 600 per unit; the highest is Zolrest at PKR 1,258. All prices are official DRAP prices.
| Brand | Company | Pack | Official price | Per unit |
|---|---|---|---|---|
| Linox | Nabiqasim Industries (Pvt) Ltd | 300mlx1's | PKR 600.00 | PKR 600 / unit |
| RADIAL | CCL Pharmaceuticals (Pvt.) Limited | 1's | PKR 963.44 | PKR 963 / unit |
| Linzolet | Winlet Pharmaceuticals (Pvt) Ltd | 1 Vial | PKR 1,144.90 | PKR 1,145 / unit |
| Linzrao | Medisave Pharmaceuticals | 1's | PKR 1,164.79 | PKR 1,165 / unit |
| Zyspan | M/s. Genix Pharma (Pvt) Ltd | 300ml x 1's | PKR 1,164.87 | PKR 1,165 / unit |
| GT Line | GT Pharma Pvt. Ltd | 1's | PKR 1,164.90 | PKR 1,165 / unit |
| Linzod | NovaMed Pharmaceuticals(Pvt.)Ltd | 1x300ml | PKR 1,196.58 | PKR 1,197 / unit |
| Nuzol | Neutro Pharma (Pvt.) Ltd | 10's | PKR 11,968.18 | PKR 1,197 / unit |
| Linzogen | Biogen Life Sciences | 1's vial | PKR 1,239.27 | PKR 1,239 / unit |
| Visoli | Vision Pharmaceuticals Pvt Ltd | 1's | PKR 1,256.27 | PKR 1,256 / unit |
| Jython | Martin Dow Limited | 1's | PKR 1,256.33 | PKR 1,256 / unit |
| Zolrest | Bosch Pharmaceuticals (Pvt) Ltd | 1's | PKR 1,258.07 | PKR 1,258 / unit |
| Barizold | Barrett Hodgson Pakistan (Pvt.) Ltd | 300 ml | PKR 1,231.67 | — |
| ECASIL | SAMI Pharmaceuticals Pvt. Ltd | 300ml Vial | PKR 1,256.33 | — |
| Enzid | Caliph Pharmaceuticals (Pvt) Ltd | 300ml | PKR 1,055.79 | — |
| Linvox | ARP (PVT) Limited | 300ml | PKR 1,075.52 | — |
| Nezolid | Searle IV Solutions (Pvt) Ltd | 300ml | PKR 1,292.27 | — |
| Xolid | Pharmasol (Pvt) Ltd | 300ml | PKR 1,107.95 | — |
| Zoldap | Getz Pharma (Pvt) Limited | 300mL | PKR 1,221.73 | — |
| Zolistat | Standpharm Pakistan Pvt Ltd | 300ml | PKR 1,107.95 | — |
Show all 21 brands
| Brand | Company | Pack | Official price | Per unit |
|---|---|---|---|---|
| Zydulid | SAFE PHARMACEUTICAL (PVT) LTD | 300ml Vial | PKR 900.58 | — |
Where to buy
MedInfoBase does not sell medicines and takes no orders. The company below holds the DRAP registration for Resbact, so it is the right place for a pharmacy, distributor or hospital buyer to ask about supply. A patient should buy from a licensed pharmacy.
- Registration holder
- Saffron Pharmaceuticals, Faisalabad
- DRAP registration
- 077082
- Phone
- +92 41 2423914-5
- info@saffronpharma.com
- Website
- https://www.saffronpharma.com/
- Contact page
- Company contact page
Contact details as published by the company, last checked on 16 August 2026 (not yet independently verified). The price on this page is the official DRAP maximum retail price: a pharmacy may charge that or less, never more.
Official price over time
No change in the official DRAP price is recorded for this pack (1’s). Current price PKR 1,256.31, effective 29 Jul 2026.
Cite this price history
MedInfoBase. Resbact 600 mg/300 mL, 1’s: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/resbact-600-mg-300-ml-077082-1s-saffron-pharmaceuticals/ (accessed 14 November 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 1,256.31 | 2026-07-29 | 2026-08-08 | DRAP PharmaPrice Index | Current |
Cite this record
Medicine record · DRAP registration 077082Price and registration data on this page were observed on 8 August 2026. Records change over time, so please cite the observation date alongside the access date.